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Abstract
Glucose homeostasis is controlled by the islets of Langerhans which are
equipped with α-cells increasing the blood glucose level, β-cells decreasing
it, and δ-cells the precise role of which still needs identifying. Although
intercellular communications between these endocrine cells have recently
been observed, their roles in glucose homeostasis have not been clearly un-
derstood. In this study, we construct a mathematical model for an islet con-
sisting of two-state α-, β-, and δ-cells, and analyze effects of known chemical
interactions between them with emphasis on the combined effects of those
interactions. In particular, such features as paracrine signals of neighboring
cells and cell-to-cell variations in response to external glucose concentrations
as well as glucose dynamics, depending on insulin and glucagon hormone,
are considered explicitly. Our model predicts three possible benefits of the
cell-to-cell interactions: First, the asymmetric interaction between α- and
β-cells contributes to the dynamic stability while the perturbed glucose level
recovers to the normal level. Second, the inhibitory interactions of δ-cells
for glucagon and insulin secretion prevent the wasteful co-secretion of them
at the normal glucose level. Finally, the glucose dose-responses of insulin
secretion is modified to become more pronounced at high glucose levels due
to the inhibition by δ-cells. It is thus concluded that the intercellular com-
munications in islets of Langerhans should contribute to the effective control
of glucose homeostasis.
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1 Introduction
Homeostasis, maintenance of the constant physiological state, is one of the
main characteristics of life. In particular, glucose homeostasis is critical
because glucose is the energy source for our bodies; the malfunctioning of
this process causes several disease states including diabetes mellitus and
brain coma.
In order to understand glucose homeostasis, we first need to examine
the tissue controlling the blood glucose level, the islet of Langerhans in the
pancreas. It consists mainly of three types of endocrine cells: α-cells which
secrete glucagon hormone increasing the glucose level, β-cells which secrete
insulin decreasing the glucose level, and δ-cells which secrete somatostatin,
known to inhibit activities of α- and β-cells. The hormone secretion of a cell
influences the behavior of neighboring cells, and is thus tightly correlated
with the islet structure (Hopcroft et al., 1985; Pipeleers et al., 1982). In
rodents, an islet contains about 1,000 endocrine cells on average: β-cells,
occupying the most volume (70 to 80%) of an islet, populate largely in its
core, whereas non-β-cells are located on the mantle (Brissova et al., 2005).
To the first approximation, α- and β-cells should be sufficient for glucose
control because α-cells can increase the glucose level whereas β-cells can de-
crease the level. The importance of this bi-hormonal mechanism for glucose
homeostasis has been well recognized (Cherrington et al., 1976). However,
it should be noted that endocrine cells in the islet interact with each other
rather than act independently. For example, the electrical coupling between
β-cells through gap-junctions is known to enhance insulin secretion of cou-
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pled β-cells (Jo et al., 2005; Pipeleers et al., 1982; Sherman et al., 1988). In
addition, it has been recently reported that chemical interactions between
neighboring cells through hormones (Cherrington et al., 1976; Franklin et al., 2005;
Orci & Unger, 1975; Ravier & Rutter, 2005; Samols et al., 1965; Samols & Harrison, 1976;
Soria et al., 2000) and neurotransmitters (Brice et al., 2002; Franklin & Wollheim, 2004;
Gilon et al., 1991; Moriyama & Hayashi, 2003; Rorsman et al., 1989; Wendt et al., 2004),
termed “paracrine interaction,” affect glucose regulation.
Among these intercellular communications, enhancement of insulin secre-
tion by glucagon (Brereton et al., 2007; Samols et al., 1965; Soria et al., 2000)
seems to be paradoxical because α-cells, playing the reciprocal role to β-cells
in glucose regulation, promote the activity of β-cells. In contrast, insulin, se-
creted by β-cells, inhibits glucagon secretion of α-cells (Cherrington et al., 1976;
Franklin et al., 2005; Ravier & Rutter, 2005; Samols & Harrison, 1976; Soria et al., 2000),
which appears natural. Furthermore, the role of the third cell-type, δ-
cells, is still not completely known although there have been reports that
somatostatin hormone, secreted by δ-cells, suppresses the hormone secre-
tion of both α- and β-cells (Cherrington et al., 1976; Daunt et al., 2006;
Orci & Unger, 1975; Soria et al., 2000).
What is then the raison d’etre of the paradoxical interactions between
α- and β-cells and the inhibitory action by δ-cells? Despite previous stud-
ies as to these questions over the last thirty years (Orci & Unger, 1975;
Pipeleers, 1987; Soria et al., 2000; Unger & Orci, 1977), there still lacks con-
crete understanding of the role of these interactions in terms of glucose
homeostasis. The primary difficulty in understanding these interactions lies
in the complexity of the islet system which includes many interactions be-
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tween different coexisting cell-types working in different conditions.
In this paper, we analyze the interactions between α-, β-, and δ-cells,
which contribute to the precise control of the glucose level, by means of a
mathematical model incorporating experimentally known interactions be-
tween islet cells (see above). As a result, our model predicts that the in-
tracellular interactions modify insulin and glucagon secretion in a way to
control the blood glucose level more efficiently.
2 Islet model
2.1 Activity of islet cells
We begin with a simplified model in which cells of each type can take one
of two states (active and silent). The state of a cell, represented by “Ising
spin” σ, is defined to be active (σ = +1) when the cell secretes islet hormone;
otherwise the state is defined as silent (σ = −1). Accordingly, the state of
an islet consisting of α-, β-, and δ-cells can be represented by (σα, σβ, σδ).
There is a total of 23 possible states of the islet, among which (+1,−1,−1)
and (−1,+1,+1) describe the islet state at low and high glucose levels, re-
spectively. The main source of changing cell states is the blood glucose level
G˜, which globally influences all cells. In addition, the paracrine interaction
J˜ from neighboring cells locally affects cell states. In this manner we obtain
a simple Ising-type model, generally characterizing two-state dynamics in
statistical physics: The glucose level G˜ corresponds to the external mag-
netic field and the paracrine interaction J˜ to the local interaction between
spins.
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¿From the known cellular interactions illustrated in Fig. 1, one may
determine local stimuli Gα, Gβ , and Gδ, which change the states of α-, β-,
and δ-cells, respectively, in the forms:
Gα = −G−
1 + σβ
2
Jαβ −
1 + σδ
2
Jαδ
Gβ = G+
1 + σα
2
Jβα −
1 + σδ
2
Jβδ
Gδ = mG, (1)
where G ≡ G˜− G˜0 measures the excess glucose level from the basal glucose
level G˜0 during the fasting period. The reciprocal nature of α- and β-cells
in the responses to glucose is manifested by the opposite signs in front of
G in the first equation (for Gα) and the second one (for Gβ) of Eq. 1. In
addition, the asymmetric interaction between these two cell types is also
reflected in the second terms involving Jαβ and Jβα of the equations. For
simplicity, we assume that the interaction strength Jβα from α- to β-cells is
the same as Jαβ from β- to α-cells and given by J1, i.e., Jαβ = Jβα = J1.
The last terms involving Jαδ and Jβδ describe the inhibition effects of δ-
cells on α- and β-cells, both with negative signs. Although the endogenous
strengths of the interactions from δ-cells to α- and β-cells are not known,
the exogenous stimulus of somatostatin has been reported to inhibit both
insulin and glucagon secretion to a similar degree (Cherrington et al., 1976).
As a first approximation, it is thus assumed that both interactions have the
same strength: Jαδ = Jβδ = J2. Here the interaction strengths J1 and
J2 are expressed in terms of the relative effects to glucose stimulation, and
therefore have the unit of mM corresponding to the hormonal stimulus J˜ ,
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namely, a given amount of stimulus J˜ by hormone is considered to produce
the same effects on a cell as a certain amount J of glucose stimulation. In our
simplified model, δ-cells are not influenced by neighboring α- and β-cells but
stimulated solely by glucose; therefore, Gδ depends only on G in Eq. 1. Like
β-cells, δ-cells become active, and secrete somatostatin above a threshold
level of glucose. The glucose sensitivity of δ-cells is expected to have a value
between zero and unity, i.e., 0 < m < 1 because the threshold level for
the activation of δ-cells is lower than that of β-cells (Efendic´ et al., 1979;
Nadal et al., 1999). We thus choose the value m = 0.5 in this study; the
overall behavior does not depend qualitatively on the value of m.
For given local stimulus Gα considering glucose stimulus G and effects
of insulin and somatostatin, the transition rate of an α-cell from state σα
to state −σα depends on the states of other cell types as well as its own
state, and is denoted as wα(σα, σβ, σδ). This transition rate should satisfy
the detailed balance condition between two α-cell states σα and −σα at
equilibrium:
wα(σα, σβ, σδ)P (σα) = wα(−σα, σβ , σδ)P (−σα), (2)
where the probability P (σα) for state σα follows the Boltzmann distribution
exp[−Gα(1 + σα)/2Θ] with respect to the quantity Gα(1 + σα)/2 for the
local stimulus Gα. Namely, α-cells favor the state minimizing the quantity
Gα(1 + σα)/2. Here Θ measures the amount of uncertainty, which is in-
evitable in biological systems. The origin may be the heterogeneous glucose
sensitivity of cells and/or the environmental noise including thermal fluc-
6
tuations. It is obvious that Gα(1 + σα)/2 and Θ correspond to the energy
and the temperature, respectively, in statistical physics. In this study, the
“temperature” is taken to be unity (Θ = 1) in units of the “energy”, which
is biologically tantamount to the fluctuations caused by 1mM change of
glucose stimulation.
The ratio between the reciprocal transition rates thus reads
wα(σα, σβ, σδ)
wα(−σα, σβ, σδ)
= exp
[
−
1
Θ
Gασα
]
= exp
[
1
Θ
(
Geffα σα +
J1
2
σασβ +
J2
2
σδσα
)]
(3)
with Geffα ≡ G + J1/2 + J2/2, where Eq. 1 has been used to obtain the
second line. There the three stimulation terms represent effective glucose
stimulation, paracrine interaction from β-cells, and another from δ-cells,
respectively. Assuming that these stimuli affect independently the α-cell
state, we write the transition rate in the form
wα =
1
2τ
[
1 + tanh
(
Geffα
2Θ
)
σα
] [
1 + tanh
(
J1
4Θ
)
σασβ
]
×
[
1 + tanh
(
J2
4Θ
)
σδσα
]
, (4)
where τ measures the characteristic time of the transition and it has been
noted that tanh(yσ) = σ tanh y for σ = ±1. Note that among possible tran-
sition rates satisfying Eq. 2, we adopt the Glauber dynamics (Glauber, 1963)
to choose the specific form of Eq. 4, which exhibits the sigmoidal form ubiq-
uitously describing response functions in biological systems. However, the
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behavior of the system in general does not depend qualitatively on the spe-
cific form of the transition rate satisfying Eq. 2. Similarly, we obtain the
transition rates wβ and wδ of β- and δ-cells.
The transition rates of three cell types can be summarized as
wx(σα, σβ, σδ) =
1
2τ
[
wx +wxασα + w
x
βσβ + w
x
δσδ + w
x
αβσασβ
+wxβδσβσδ + w
x
δασδσα + w
x
αβδσασβσδ
]
, (5)
with x = α, β, and δ, where the coefficients are given in Tables 1 and 2. The
master equation, describing the evolution of the probability P (σα, σβ , σδ)
for the islet in state (σα, σβ , σδ), reads
d
dt
P (σα, σβ, σδ)
= wα(−σα, σβ, σδ)P (−σα, σβ , σδ) + wβ(σα,−σβ , σδ)P (σα,−σβ, σδ)
+ wδ(σα, σβ ,−σδ)P (σα, σβ,−σδ)− wα(σα, σβ, σδ)P (σα, σβ, σδ)
− wβ(σα, σβ , σδ)P (σα, σβ , σδ)−wδ(σα, σβ , σδ)P (σα, σβ , σδ) (6)
with the transition rates wα, wβ, and wδ in Eq. 5. Note that Eq. 6 describes
the net flux to state (σα, σβ , σδ) simply given by the difference between the
in-flux to state (σα, σβ, σδ) from other states (−σα, σβ , σδ), (σα,−σβ, σδ),
and (σα, σβ,−σδ) and the out-flux from state (σα, σβ, σδ) to others.
¿From this master equation, it is straightforward to obtain the time
evolution of the ensemble averages of the cell states and their correlations.
For example, multiplying both sides of Eq. 6 by σα and summing over all
configurations, we obtain the evolution equation for the average 〈σα〉 ≡
8
∑
σα,σβ ,σδ
σαP (σα, σβ, σδ) of the state of α-cells:
d
dt
〈σα〉 = −2〈σαwα(σα, σβ , σδ)〉 (7)
and similarly,
d
dt
〈σβ〉 = −2〈σβwβ(σα, σβ, σδ)〉 (8)
d
dt
〈σδ〉 = −2〈σδwα(σα, σβ, σδ)〉. (9)
Note that 1 + 〈σα〉 gives twice the average activity of α-cells, etc.
Among the eight equations for the probability P (σα, σβ, σδ) correspond-
ing to the eight possible states of the islet, only seven are independent, due
to the normalization condition
∑
σα,σβ ,σδ
p(σα, σβ, σδ) = 1. Therefore, there
exist four more equations in addition to the above three describing the av-
erage of cell states. Those are evolution equations for correlations of two
cell states and of three cell states. The equation for the correlation func-
tion 〈σασβ〉 of the α-cell and β-cell states can again be derived from Eq. 6,
multiplied by σασβ and summed over all configurations:
d
dt
〈σασβ〉 = −2〈σασβwα(σα, σβ , σδ)〉 − 2〈σασβwβ(σα, σβ, σδ)〉. (10)
The equations for 〈σβσδ〉 and 〈σδσα〉 are also obtained in the same way:
d
dt
〈σβσδ〉 = −2〈σβσδwβ(σα, σβ , σδ)〉 − 2〈σβσδwδ(σα, σβ , σδ)〉
d
dt
〈σδσα〉 = −2〈σδσαwδ(σα, σβ , σδ)〉 − 2〈σδσαwα(σα, σβ, σδ)〉. (11)
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Note that correlations of two cell states represent the relative activity of the
two cells. Accordingly, it makes a good measure of the different responses
between two cells. Similarly, the equation for correlations of three cell states
is given by
d
dt
〈σασβσδ〉 = −2〈σασβσδwα(σα, σβ , σδ)〉 − 2〈σασβσδwβ(σα, σβ, σδ)〉
−2〈σασβσδwδ(σα, σβ, σδ)〉. (12)
Substituting the transition rates in Eq. 5 into Eqs. 7 to 12, we finally
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obtain equations for the states of the three cell types and their correlations:
τ
d
dt
〈σα〉 = −w
α
α − w
α〈σα〉 − w
α
αβ〈σβ〉 − w
α
δα〈σδ〉 − w
α
β 〈σασβ〉
−wααβδ〈σβσδ〉 − w
α
δ 〈σδσα〉+ w
α
βδ〈σασβσδ〉
τ
d
dt
〈σβ〉 = −w
β
β − w
β
αβ〈σα〉 − w
β〈σβ〉 − w
β
βδ〈σδ〉 − w
β
α〈σασβ〉
−wβδ 〈σβσδ〉 − w
β
αβδ〈σδσα〉 − w
β
δα〈σασβσδ〉
τ
d
dt
〈σδ〉 = −w
δ
δ − w
δ
δα〈σα〉 − w
δ
βδ〈σβ〉 − w
δ〈σδ〉 − w
δ
αβδ〈σασβ〉
−wδβ〈σβσδ〉 − w
δ
α〈σδσα〉 −w
δ
αβ〈σασβσδ〉
τ
d
dt
〈σασβ〉 = −(w
α
αβ + w
β
αβ)− (w
α
β +w
β
β)〈σα〉 − (w
α
α + w
β
α)〈σβ〉
−(wααβδ + w
β
αβδ)〈σδ〉 − (w
α + wβ)〈σασβ〉
−(wαδα + w
β
δα)〈σβσδ〉 − (w
α
βδ +w
β
βδ)〈σδσα〉
−(wαδ + w
β
δ )〈σασβσδ〉
τ
d
dt
〈σβσδ〉 = −(w
β
βδ + w
δ
βδ)− (w
β
αβδ +w
δ
αβδ)〈σα〉 − (w
β
δ + w
δ
δ)〈σβ〉
−(wββ + w
δ
β)〈σδ〉 − (w
β
δα + w
δ
δα)〈σασβ〉
−(wβ + wδ)〈σβσδ〉 − (w
β
αβ + w
δ
αβ)〈σδσα〉
−(wβα + w
δ
α)〈σασβσδ〉
τ
d
dt
〈σδσα〉 = −(w
δ
δα + w
α
δα)− (w
δ
δ + w
α
δ )〈σα〉 − (w
δ
αβδ + w
α
αβδ)〈σβ〉
−(wδα + w
α
α)〈σδ〉 − (w
δ
βδ + w
α
βδ)〈σασβ〉
−(wδαβ + w
α
αβ)〈σβσδ〉 − (w
δ +wα)〈σδσα〉
−(wδβ + w
α
β )〈σασβσδ〉
τ
d
dt
〈σασβσδ〉 = −(w
α
αβδ + w
β
αβδ + w
δ
αβδ)− (w
α
βδ + w
β
βδ + w
δ
βδ)〈σα〉
−(wαδα + w
β
δα + w
δ
δα)〈σβ〉 − (w
α
αβ + w
β
αβ + w
δ
αβ)〈σδ〉
−(wαδ + w
β
δ + w
δ
δ)〈σασβ〉 − (w
α
α + w
β
α + w
δ
α)〈σβσδ〉
−(wαβ + w
β
β + w
δ
β)〈σδσα〉 − (w
α + wβ + wδ)〈σασβσδ〉.(13)
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2.2 Glucose homeostasis
Heretofore we have focused on the cellular interactions at a given glucose
level. To study dynamics of glucose homeostasis, however, we should also
take into account the change of the glucose level and incorporate another
equation for glucose regulation into the model. Based on the fact that α-
and β-cells secrete glucagon and insulin, respectively, raising and reducing
the glucose level, the equation for the glucose level G is taken to be
τG
dG
dt
=
1 + 〈σα〉
2
−
1 + 〈σβ〉
2
, (14)
where τG is the characteristic time for the hormones to regulate the glucose
level. It is expected that τG is larger than the characteristic time τ of the
change in cell states. Equation 14 describes the decrease or increase of the
glucose level when α-cells or β-cells are active (σα = 1 or σβ = 1). Here,
for simplicity, we have used the same characteristic time τG for glucagon
and insulin to regulate glucose levels. Having different time constants turns
out merely to shift the stationary level of blood glucose. To sum, we have a
total of eight differential equations given by Eqs. 13 and 14, which describe
the process of glucose homeostasis.
3 Results
3.1 Asymmetric interactions between α- and β-cells
In our model, activities of α-, β-, and δ-cells are determined by the exter-
nal glucose level together with feedback loops of intercellular interactions.
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A given cell, subject to a glucose stimulus, secretes hormone which influ-
ences the behavior of neighboring cells. In response, the neighboring cells
reversely influence the given cell. These mutual interactions through hor-
mones constitute the feedback loop which is widely employed for advanced
system control in engineering (Bechhoefer, 2005).
The interactions between α- and β-cells are asymmetric: While glucagon
secreted from α-cells enhances insulin secretion of β-cells (Brereton et al., 2007;
Samols et al., 1965; Soria et al., 2000), insulin inhibits glucagon secretion (Cherrington et al., 1976;
Franklin et al., 2005; Ravier & Rutter, 2005; Samols & Harrison, 1976; Soria et al., 2000).
The former positive interaction to the counterpart cells may seem strange,
but it eventually contributes to the construction of a negative feedback loop
for both cells. At low glucose levels, α-cells secrete glucagon, which enhances
insulin secretion. In turn, insulin inhibits the glucagon secretion of α-cells.
Therefore, their interactions as a whole tend to suppress the glucagon se-
cretion from α-cells. Similar negative feedback operates when β-cells are
activated by high glucose concentration. It is noteworthy that this feedback
works more efficiently in case that the glucose level varies. At a static glu-
cose level, it should be difficult for the mutual interactions between α- and
β-cells to arise simultaneously because insulin and glucagon are secreted at
different glucose levels.
In general, a negative feedback favors stability of a system because it
attenuates overaction of the system such as overshoot or undershoot. The
negative feedbacks in an islet system contribute to the stable recovery to
the normal glucose level G∞, when the system is externally perturbed by
stimuli such as a glucose dose. The normal glucose level G∞, reached by
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G (≡ G˜− G˜0) at stationarity, depends on the cellular interactions shown in
Fig. 2. The asymmetric interaction J1 lowers the basal glucose level because
α-cells activate β-cells which secret insulin and thus reduces the glucose
level. In addition, the inhibitory interaction J2 of δ-cells, albeit the same
for α- and β-cells, suppresses the activity of β-cells more than that of α-cells
at the normal glucose level, because the activity of β-cells is higher than that
of α-cells resulting from the asymmetric interaction between α- and β-cells.
Accordingly, the basal glucose level tends to increase as the strength J2 of
the inhibitory interaction is increased.
Figure 3 demonstrates the smooth recovery of the glucose level in the
presence of cellular interactions (solid line), compared with the somewhat
erratic recovery, once reaching low glucose levels, in the absence of the inter-
actions (dashed line). For comparison, we also consider the behavior in the
case of symmetric interactions between α- and β-cells, i.e., where glucagon
inhibits insulin secretion and vice versa, only to find even more erratic recov-
ery (see the dotted line). Shown here is the recovery from the high glucose
state [G = 1mM (or G˜ = G˜0 + 1mM), 〈σα〉 = −1, and 〈σβ〉 = 1]. The
recovery from a low glucose state gives the same results (data not shown)
although such erratic recovery is more pronounced for the glucose level start-
ing from a higher value.
To examine the stability in approaching the normal glucose level, we
define the balance function
b(G) ≡ τG
dG
dt
=
1 + 〈σα〉
2
−
1 + 〈σβ〉
2
, (15)
14
which describes the glucose level change during the characteristic time. Since
the activity of cells represents their hormone secretion, b(G) appropriately
describes the effectiveness of the glucose regulation by α- and β-cells. If
the characteristic time τG of glucose regulation is much larger than the
characteristic time τ of cell responses in Eq. 13, i.e., τ ≪ τG, the glucose
level should be in a quasi-stationary state at time t shorter than τG. Then the
fast dynamics of cell states in Eq. 13 saturates rapidly at a given glucose level
and the seven variables, activities and correlations, reach their fixed points
depending on the glucose level G. In particular 〈σα〉 and 〈σβ〉 depend on G,
giving the balance function in Eq. 15 as a function of G, with a fixed point at
G = G∞ (see Fig. 4). At low glucose levels (G < G∞), we have the balance
function greater than zero (b > 0), or dG/dt > 0, thus the glucose level
grows with time. At high glucose levels (G > G∞), the opposite behavior
arises. The resulting flow of the balance function is illustrated by the arrows
in Fig. 4 and it is concluded that the balance function correctly describes
glucose homeostasis. Further, the slope of b(G) near the fixed point G = G∞
represents how smoothly the glucose level approaches the normal level: The
slope of the balance function for the asymmetric interaction is small at
G = G∞, which results in the smooth recovery of the normal glucose level
shown in Fig. 3. This result is more evident with the interaction strength
J1 larger and the characteristic time τG shorter.
If α- and β-cells would inhibit each other, how should the result change?
As suggested already (Saunders et al., 1998), the bidirectional inhibitory in-
teractions seem to be optimal in view of that α- and β-cells play opposite
roles in glucose regulation. Remarkably, however, such symmetric interac-
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tions turn out to result in dynamically unstable responses, as shown by the
dotted line in Fig. 3. If this were the case, glucagon secreted by α-cells
at low glucose levels would suppress β-cells from secreting insulin. As the
secretion of insulin decreases, so would the inhibitory effects of insulin on
the glucagon secretion diminish. It should thus follow that glucagon secre-
tion is not negatively controlled, implying more glucagon secretion. Such an
apparent positive feedback loop, enhancing hormone secretion, gives rise to
an instability in the islet system (see Fig. 3).
3.2 Inhibitory interactions of δ-cells
3.2.1 Suppression of co-secretion from α- and β-cells
There is basal hormone secretion from α- and β-cells even at the normal
glucose level (Cherrington et al., 1976), where it is not necessary to change
the blood glucose concentration with the help of glucagon or insulin. Ob-
viously, the simultaneous secretion of glucagon and insulin at the normal
level should be minimized because the opposite effects of the two would
cancel out, nullifying the net effects on the glucose level. Such wasteful co-
secretion of counteracting hormones can be prevented by δ-cells secreting
somatostatin, which inhibits secretion of both glucagon and insulin.
In our model, the average activity of cells is given by (1+〈σ〉)/2. Accord-
ingly, the average cell state 〈σ〉 = ±1 means that all cells are active/silent;
in particular 〈σ〉 = 0 corresponds to half of the cells being active. In the
absence of the inhibitory interaction of δ-cells, Fig. 5(a) shows that both
〈σα〉 and 〈σβ〉 take values greater than −1 even at the normal glucose level.
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Namely, fluctuations associated with the biological uncertainty Θ have some
fraction of cells still active, leading to basal hormone secretion. Here the
presence of inhibitory interactions of δ-cells lowers the basal activity of α-
and β-cells, as shown in Fig. 5(b), which reduces co-secretion of the coun-
teracting hormones, glucagon and insulin.
Figure 6 displays the relation between 〈σα〉 and 〈σβ〉, in the absence
(J2 = 0mM) and presence (J2 = 2mM) of the inhibitory interaction of δ-
cells. The system at low or high glucose levels is described by the upper
left or lower right parts of the curves on the (〈σβ〉, 〈σα〉) plane, respectively.
Namely, when the glucose concentration is low, α- and β-cells are in high
and in low activity, respectively (〈σα〉 > 0 and 〈σβ〉 < 0); this is reversed at
high glucose concentrations. It is manifested that the inhibitory interaction
of δ-cells reduces simultaneous activation of α- and β-cells. Compared with
the result for J2 = 0mM (dashed line), the result for J2 = 2mM (solid line)
shows that the activity of β- or α-cells is reduced substantially at high or
low glucose levels. In particular α-cells remain almost silent (〈σα〉 ≈ −1) at
high glucose levels. Note, however, that those endocrine cells are not totally
silent at given glucose levels and still exhibit residual activity, which results
from fluctuations in the glucose responses of the cells. Interestingly, it was
suggested that such basal hormone secretion also plays an effective role:
The minimal basal secretion of glucagon compensates the glucose uptake in
the liver while basal secretion of insulin inhibits over-secretion of the basal
glucagon (Cherrington et al., 1976).
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3.2.2 Enhancement of glucose dose-responses of β-cells
Another consequence of the inhibitory interaction of δ-cells is the shift of
glucose dose-responses for insulin secretion to the right direction. This is
associated with the increased control of β-cells by δ-cells at high glucose lev-
els. Figure 7 indeed shows that the shift leads to more conspicuous glucose
responses of β-cells at high glucose levels. In general β-cells are coupled
with each other through gap-junction channels, which help the cells syn-
chronize their behaviors (Sherman & Rinzel, 1991). A β-cell cluster thus
tends to produce all-or-none glucose responses (Soria et al., 2000). In the
real islet, on the other hand, δ-cells, with their inhibitory interactions de-
pending on the glucose level, can modify the glucose dose-response of β-cells.
Accordingly, insulin response can be more pronounced at high glucose levels
(G > 0).
It is observed that some primitive animals have only β- and δ-cells in
their islets, unlike the mammals whose islets contain α-cells as well as β-
and δ-cells (Falkmer, 1985). This difference could perhaps be attributed to
an evolutionary adaptation. At early evolutionary stages, the islet might
be a passive system: Without α-cells directly increasing the glucose level,
the glucose level should increase passively as a result of the decrease in
insulin secretion. Still, the precise glucose dose-responses at high glucose
levels could be possible with δ-cells. At later stages, equipped with α-
cells, the islet became an active system with regard to glucose regulation.
It is of interest that this evolutionary change is correlated with the fact
that β- and δ-cells are closer to each other than α-cells in the develop-
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ment of a stem cell (Kemp et al., 2003). In addition, β- and δ-cells have
functional similarities of using ATP-dependent K+ channels in glucose re-
sponses (Quesada et al., 2006; Quesada et al., 1999).
4 Discussions
The islet of Langerhans is a precise system that controls the glucose level
through the use of three main types of endocrine cells. Here it is of in-
terest to investigate whether the existing interactions between those cells
are beneficial for glucose homeostasis. There are some evidence for the
critical role of the interactions, which may not obviously be addressed by
probing α- and β-cells separately. The molecular mechanism of how α-cells
regulate glucagon secretion at variable glucose levels is still not clearly un-
derstood (Gromada et al., 2007). Several works attempted to explain this
by means of the interactions between α- and β-cells: At high glucose lev-
els, glucagon secretion is inhibited by insulin, GABA, or Zn2+ secreted from
β-cells (Gromada et al., 2007; Ishihara et al., 2003). There is also a hypoth-
esis that glucose has direct effects on α-cells through endoplasmic reticulum
Ca2+ storage (Vieira et al., 2006). Another evidence for the role of cellular
interactions in glucose homeostasis comes from hyperglucagonomia, which
occurs in diabetics at abnormally high glucose levels. It appears paradoxi-
cal that the glucagon levels of such patients are high even though the blood
glucose levels are high enough to make α-cells silent (Gromada et al., 2007).
This puzzling result can be explained on the basis of cellular interactions in
an islet (Franklin et al., 2005; Rorsman et al., 1989; Takahashi et al., 2006).
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Note that there is also another explanation of this phenomenon in terms of
the peculiar glucose dose-responses of (rat) α-cells (Kemp et al., 2003).
In contrast, there also exist a few reports that some cellular interactions
may not exist and are not necessary for glucose homeostasis: It has been
proposed that the microcirculation from β- to peripheral α- and δ-cells pro-
hibits the paracrine action from non-β to β-cells (Wayland, 1997). In addi-
tion, it has recently been reported that islet transplantation is successful in
recovering from hyperglycaemia with only β-cell clusters (King et al., 2007).
Nevertheless, the existence of the receptors of signalling molecules such
as insulin, glucagon, somatostatin, glutamate, and GABA, which are ex-
pressed in pancreatic endocrine cells, apparently implicates their physi-
ological roles in the fine control of glucose levels (Gromada et al., 2007;
Strowski & Blake, 2008). A better understanding of this tissue, therefore,
will contribute to more advanced medical treatment of diabetes than the
current one relying mostly on insulin. For example, it is conceivable to
use other hormones such as glucagon and somatostatin for more active and
precise glucose control.
A variety of complicated interactions in an islet makes it difficult to
recognize their roles, and existing experiments as to those interactions have
focused mostly on static responses of the endocrine cells. However, it is likely
that the cellular interactions actually contribute to dynamical responses to
glucose. In this study, therefore, to understand the role of intercellular in-
teractions between α-, β-, and δ-cells, we have proposed an islet model and
investigated the effects of integrated intercellular communications between
those cells in glucose homeostasis. Our mathematical model can systemati-
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cally include all the cellular interactions and identify their effects on static
and/or dynamic responses to external glucose changes. It also takes individ-
ual heterogeneities into consideration, e.g., in glucose sensitivity; the basal
hormone secretion at the normal glucose level reflects that some cells can be
active to secrete hormones even though most of the cells are silent at that
glucose level. The small variations in glucose responses among homologous
cells may contribute crucially to the cellular interactions between heterol-
ogous cells, which are actually activated in quite different glucose concen-
trations, because the heterogeneous responses of homologous cells can lead
to an overlap in the activation between the heterologous cells. ¿From this
model, it has been revealed that the interactions give more stable, efficient,
and accurate control of glucose: First, asymmetric interactions between α-
and β-cells contribute to the dynamic stability when the glucose level, per-
turbed from the normal level, recovers to the latter. Second, the interactions
of somatostatin for glucagon and insulin secretion prevent their wasteful co-
secretion at the normal glucose level. In addition, at high glucose levels, the
inhibition by δ-cells modifies glucose dose-responses of insulin secretion. For
a more realistic and accurate understanding, it would be necessary to know
the physiological values of the model parameters. In particular, the relative
effects of the direct glucose stimulus G and paracrine interactions J on the
states of endocrine cells should be identified.
Here it is proposed that these predictions can be verified in experiment.
As for the role of δ-cells, our results may be confirmed through the use
of cell clusters of different compositions of cell-types, for which the culture
method was used in the existing study (Pipeleers et al., 1982). Another
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prediction related with the asymmetric interactions between α- and β-cells
needs to be verified in vivo experiment on transgenic mice because the effects
should arise in the dynamics of whole-body glucose regulation. Note that
the specific cellular interaction may be blocked selectively in knockout mice
lacking specific hormone receptors in an endocrine cell (Diao et al., 2005;
Sorensen et al., 2006).
Beyond the interactions between endocrine cells analyzed in this study,
there exist reports that δ-cells are also influenced by α- and β-cells (Unger & Orci, 1977)
and these paracrine interactions should be considered with the microcircula-
tion of hormones in an islet as described above (Wayland, 1997). It has also
been reported that there exist autocrine interactions via which a cell is af-
fected by its own hormone secretion (Aspinwall et al., 1999; Cabrera et al., 2008).
Furthermore, input from exocrine cells (Bertelli et al., 2001; Bishop & Polak, 1997;
Wayland, 1997) and glucose-sensing neurons (Schuit et al., 2001) have been
suggested. There may thus be more complex communications in the pan-
creas for glucose homeostasis, which are left for further study. Finally, we
also point out that the mathematical model proposed can be generalized to
describe cellular interactions in other systems, e.g., neural networks consist-
ing of excitatory and inhibitory couplings.
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Table 1: Coefficients in the transition rate. Here kx ≡ (gx + jx1 + j
x
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x)−1 with x denoting α, β, or δ. Parameters
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2 are given in Table 2.
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Table 2: Parameters in the coefficients of the transition rate.
x α β δ
gx tanh(G/2Θ) tanh(−G/2Θ) tanh(−mG/2Θ)
jx1 tanh(J1/4Θ) tanh(−J1/4Θ) 0
jx2 tanh(J2/4Θ) tanh(J2/4Θ) 0
31
Figure Legends
Figure 1.
Schematic diagram of cellular interactions between α-, β-, and δ-cells. The
arrow represents enhancement while bars represent inhibition. Here the
intercellular interactions between two cells are present only when both are
in active states.
Figure 2.
Stationary glucose level G∞, depending on the cellular interaction strengths
J1 and J2. Note that G∞ measures the stationary level relative to the fasting
glucose level G˜0 in the absence of cellular interactions.
Figure 3.
Time evolution of the glucose level G, depending on the interactions between
α- and β-cells. Starting from the high-glucose state [〈σα〉 = −1 and 〈σβ〉 = 1
at G = 1mM (or G˜ = G˜0 + 1mM)], the system recovers eventually the
normal glucose level G∞. The time constants are taken to be τ = τG = 1
for simplicity and the cellular interactions have strengths J1 = 2mM and
J2 = 0mM.
Figure 4.
Balance function for glucose regulation, depending on the interactions be-
tween α- and β-cells. The strengths of cellular interactions are J1 = 2mM
and J2 = 0mM.
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Figure 5.
Time evolution of the average states 〈σα〉 and 〈σβ〉 of α- and β-cells, starting
initially from the high-glucose state 〈σα〉 = −1 and 〈σβ〉 = 1 at G = 1mM,
during the recovery to the normal glucose level. The asymmetric interactions
between α- and β-cells have the strength J1 = 2mM whereas the inhibitory
interactions of δ-cells are absent in (a) J2 = 0mM but present in (b) J2 =
2mM.
Figure 6.
The average state 〈σα〉 of α-cells versus 〈σβ〉 of β-cells for the asymmetric
interaction J1 = 2mM, in the absence (J2 = 0mM) and presence (J2 =
2mM) of the inhibitory interaction of δ-cells. The dotted line along the
diagonal represents the stationary condition 〈σα〉 = 〈σβ〉.
Figure 7.
Glucose dose-responses in the activity of β-cells for the inhibitory interac-
tion J2 = 0 and 2mM. The asymmetric interactions are taken to have the
strength J1 = 2mM.
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